Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.

RPEP-083622024Hegab, Islam Ibrahim; El-Horany, Hemat El-Sayed; Abd-Ellatif, Rania Nagi; Nasef, Nahla Anas; Okasha, Asmaa H; Emam, Marwa Nagy; Hassan, Shereen; Elseady, Walaa S; Radwan, Doaa A; ElEsawy, Rasha Osama; Hafez, Yasser Mostafa; Hassan, Maha Elsayed; Mansour, Nouran Mostafa; Abdelkader, Gamaleldien Elsayed; Fouda, Mohamed H; Abd El Maged, Amira M; Abdallah, Hanan M

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.

International journal of molecular sciences, 26(1)

View on PubMed ↗Publisher’s paper ↗

Citation

Hegab, Islam Ibrahim; El-Horany, Hemat El-Sayed; Abd-Ellatif, Rania Nagi; Nasef, Nahla Anas; Okasha, Asmaa H; Emam, Marwa Nagy; Hassan, Shereen; Elseady, Walaa S; Radwan, Doaa A; ElEsawy, Rasha Osama; Hafez, Yasser Mostafa; Hassan, Maha Elsayed; Mansour, Nouran Mostafa; Abdelkader, Gamaleldien Elsayed; Fouda, Mohamed H; Abd El Maged, Amira M; Abdallah, Hanan M. (2024). Adropin/Tirzepatide Combination Mitigates Cardiac Metabolic Aberrations in a Rat Model of Polycystic Ovarian Syndrome, Implicating the Role of the AKT/GSK3β/NF-κB/NLRP3 Pathway.. International journal of molecular sciences, 26(1). https://doi.org/10.3390/ijms26010001